Skip to main content
Erschienen in: World Journal of Urology 6/2012

01.12.2012 | Original Article

Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy

verfasst von: M. Lodde, R. Mayr, T. Martini, E. Comploj, S. Palermo, E. Trenti, E. Hanspeter, H. M. Fritsche, C. Mian, A. Pycha

Erschienen in: World Journal of Urology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

A second transurethral resection of the bladder (TURB) is recommended for high-grade bladder cancer (BC) yet yields negative results in over half of the cases. Aim of this study was to identify prognostic indicators of a positive second TURB or the need for a subsequent cystectomy.

Materials and methods

The study cohort consisted of 101 patients with high-risk BC (T1G2-3, TaG3, Carcinoma in situ) who underwent second TURB after complete first resection. Age, gender, stage, grade, carcinoma in situ (Cis), tumour number, size, localization, surgeon experience and bladder wash cytology before the second TURB were considered as potential prognostic factors of positive histology at second TURB or the need for subsequent cystectomy.

Results

The mean follow-up period was 23.8 months. The study cohort was comprised of 82 males and 17 females. Cytology on bladder wash urine was performed in 85/101 patients and in 39 was negative; 55.5 % of second TURB specimens were negative. The rate of upstaging to ≥T2 was 4.9 %. Cis (OR 8.4; 95 % CI 1.3–54.2; p = 0.03) and positive cytology (OR 6.8; 95 % CI 2.3–19.9; p = <0.01) were independent prognostic factors of a residual tumour in the second TURB. Cytology also correlated with clinical need for cystectomy in the follow-up (HR 6.5; 95 % CI 1.3–30.5; p = 0.02).

Conclusions

CIS and positive cytology prior to second TURB increased the risk of a positive second TURB specimen. A positive cytology also increases the risk of the subsequent need for cystectomy.
Literatur
1.
Zurück zum Zitat Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M (2011) European association of urology (EAU) guidelines 4–35 Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M (2011) European association of urology (EAU) guidelines 4–35
2.
Zurück zum Zitat Soloway M, Sofer M, Vaidya A (2002) Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167:1573–1583PubMedCrossRef Soloway M, Sofer M, Vaidya A (2002) Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167:1573–1583PubMedCrossRef
3.
Zurück zum Zitat Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ (2002) EORTC Genito-Urinary Tract Cancer Collaborative Group. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41(5):523PubMedCrossRef Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ (2002) EORTC Genito-Urinary Tract Cancer Collaborative Group. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41(5):523PubMedCrossRef
4.
Zurück zum Zitat Boström PJ, Alkhateeb S, van Rhijn BW, Kuk C, Zlotta AR (2010) Optimal timing of radical cystectomy in T1 high-grade bladder cancer. Expert Rev Anticancer Ther 10(12):1891–1902PubMedCrossRef Boström PJ, Alkhateeb S, van Rhijn BW, Kuk C, Zlotta AR (2010) Optimal timing of radical cystectomy in T1 high-grade bladder cancer. Expert Rev Anticancer Ther 10(12):1891–1902PubMedCrossRef
5.
Zurück zum Zitat Schips L, Augustin H, Zigeuner RE et al (2002) Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 59:220–223PubMedCrossRef Schips L, Augustin H, Zigeuner RE et al (2002) Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 59:220–223PubMedCrossRef
6.
Zurück zum Zitat Mariappan P, Zachou A, Grigor KM (2010) Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57(5):843–849PubMedCrossRef Mariappan P, Zachou A, Grigor KM (2010) Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57(5):843–849PubMedCrossRef
7.
Zurück zum Zitat Soloway MS, Pate J (1991) Surgical techniques for endoscopic resection of bladder cancer. Urol Clin North Am 19:467–471 Soloway MS, Pate J (1991) Surgical techniques for endoscopic resection of bladder cancer. Urol Clin North Am 19:467–471
8.
Zurück zum Zitat Koss LG, Deitch D, Ramanathan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29:810–816PubMed Koss LG, Deitch D, Ramanathan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29:810–816PubMed
9.
Zurück zum Zitat Mostofi FK, Davis CJ, Sesterhenn IA, World health organization histological typing of urinary bladder tumours (2nd ed)Springer Verlag, Berlin (1999) Mostofi FK, Davis CJ, Sesterhenn IA, World health organization histological typing of urinary bladder tumours (2nd ed)Springer Verlag, Berlin (1999)
10.
Zurück zum Zitat Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162(1):74–76PubMedCrossRef Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162(1):74–76PubMedCrossRef
11.
Zurück zum Zitat Koermann KU, Woeste M, Kappes j (1994) Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 25:208CrossRef Koermann KU, Woeste M, Kappes j (1994) Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 25:208CrossRef
12.
Zurück zum Zitat Herr HW, Donat SM, Dalbagni G (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy. J Urol 177(1):75–79PubMedCrossRef Herr HW, Donat SM, Dalbagni G (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy. J Urol 177(1):75–79PubMedCrossRef
13.
Zurück zum Zitat Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M (2011) European Association of Urology (EAU).EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the (2011) update. Eur Urol 59(6):997–1008CrossRef Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M (2011) European Association of Urology (EAU).EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the (2011) update. Eur Urol 59(6):997–1008CrossRef
14.
Zurück zum Zitat Herr HW, Donat SM (2008) Quality control in transurethral resection of bladder tumours. BJU Int 102(9 Pt B):1242–1246PubMedCrossRef Herr HW, Donat SM (2008) Quality control in transurethral resection of bladder tumours. BJU Int 102(9 Pt B):1242–1246PubMedCrossRef
15.
Zurück zum Zitat Herr HW (2005) Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174(6):2134–2137PubMedCrossRef Herr HW (2005) Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174(6):2134–2137PubMedCrossRef
16.
Zurück zum Zitat Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, Tammela TL (2002) FinnBladder Group. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 41(3):284–289 Raitanen MP, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, Tammela TL (2002) FinnBladder Group. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 41(3):284–289
17.
Zurück zum Zitat Karakiewicz PI, Benayoun S, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF (2006) Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 97(5):997–1001PubMedCrossRef Karakiewicz PI, Benayoun S, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF (2006) Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 97(5):997–1001PubMedCrossRef
18.
Zurück zum Zitat Mian C, Maier K, Comploj E, Lodde M, Berner L, Lusuardi L, Palermo S, Vittadello F, Pycha A (2006) uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses. Cancer 108(1):60–65PubMedCrossRef Mian C, Maier K, Comploj E, Lodde M, Berner L, Lusuardi L, Palermo S, Vittadello F, Pycha A (2006) uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses. Cancer 108(1):60–65PubMedCrossRef
Metadaten
Titel
Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy
verfasst von
M. Lodde
R. Mayr
T. Martini
E. Comploj
S. Palermo
E. Trenti
E. Hanspeter
H. M. Fritsche
C. Mian
A. Pycha
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 6/2012
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0975-1

Weitere Artikel der Ausgabe 6/2012

World Journal of Urology 6/2012 Zur Ausgabe

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.